Ras signalling and apoptosis

Current Opinion in Genetics and Development

Volumn 8, Issue 1, 1998, Pages 49-54

  Downward, Julian ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; PROTEIN P53; RAF PROTEIN; RAS PROTEIN;

APOPTOSIS; CELL CYCLE; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0031936353     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(98)80061-0     Document Type: Article

References (60)

1. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 49:1989;4682-4689.
2. Downward J. Cell cycle: routine role for Ras. Curr Biol. 7:1997;258-260.
3. Lowy DR, Willumsen BM. Function and regulation of RAS. Annu Rev Biochem. 62:1993;851-891.
4. McCormick F. Signal transduction: how receptors turn Ras on. Nature. 363:1993;15-16.
5. Marshall CJ. Ras effectors. Curr Opin Cell Biol. 8:1996;197-204.
6. Marte BM, Downward J. PKB/Akt: connecting PI3-kinase to cell survival and beyond. Trends Biochem Sci. 22:1997;355-358.
7. Stephens LR, Jackson TR, Hawkins PT. Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system. Biochim Biophys Acta. 1179:1993;27-75.
8. Feig LA, Urano T, Cantor S. Evidence for a ras/ral signaling cascade. Trends Biochem Sci. 21:1996;438-441.
9. Adler V, Pincus MR, Brandtrauf PW, Ronai Z. Complexes of p21(ras) with jun N-terminal kinase and jun proteins. Proc Natl Acad Sci USA. 92:1995;10585-10589.
10. Russell M, Lange-Carter C, Johnson GL. Direct interaction between ras and the kinase domain of mitogen activated protein kinase kinase kinase (mekk1). J Biol Chem. 270:1995;11757-11760.
11. ras in ras-induced apoptosis. J Biol Chem. 271:1996;2376-2379.
12. Diaz-Meco MT, Lozano J, Municio MM, Berra E, Frutos S, Sanz L, Moscat J. Evidence for the in vitro and in vivo interaction of ras with protein kinase C zeta. J Biol Chem. 269:1994;31706-31710.
13. Diaz-Meco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L, Moscat J. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell. 86:1996;777-786.
14. Nikiforov MA, Hagen K, Ossovskaya VS, Connor TMF, Lowe SW, Deichman GI, Gudkov AV. p53 modulation of anchorage independent growth and experimental metastasis. Oncogene. 13:1996;1709-1719.
15. McGill G, Shimamura A, Bates RC, Savage RE, Fisher DE. Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol. 138:1997;901-911.
16. -/- mouse embryo fibroblasts. Oncogene. 13:1996;739-748.
17. Trent JC, McConkey DJ, Loughlin SM, Harbison MT, Fernandez A, Ananthaswamy HN. Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J. 15:1996;4497-4505.
18. Kauffman-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G. Suppression of c-myc-induced apoptosis by Ras signaling through PI(3)K and PKB. of outstanding interest Nature. 385:1997;544-548 The effect of activated Ras on fibroblast survival in the absence of serum with forced Myc expression is shown to be the sum of a death-inducing signal mediated by the Raf, a MAP kinase pathway and a survival signal mediated by PI3-kinase, PKB/Akt.
19. Fukasawa K, Vande Woude GF. Synergy between the mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol. 17:1997;506-518.
20. Lloyd AC, Obermuller F, Staddon S, Barth C, McMahon M, Land H. Cooperating oncogenes target cyclin/cdk activity. of special interest Genes Dev. 11:1997;663-677 Although not dealing with apoptosis directly, this paper, together with [21], establishes the important point that strong constitutive stimulation of Ras and Raf can lead to increased levels of p53, p16 and p21 in fibroblasts, resulting in cell cycle arrest.
21. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. of special interest Cell. 88:1997;593-602 See annotation [20].
22. Fukasawa K, Rulong S, Resau J, Pinto da Silva P, Woude GF. Overexpression of mos oncogene product in Swiss 3T3 cells induces apoptosis preferentially during S-phase. Oncogene. 10:1995;1-8.
23. WAF1/CIP1. The ability of Ras to control cell cycle checkpoints such as this suggests an indirect mechanism by which it may influence apoptosis.
24. Latinis KM, Carr LL, Peterson EJ, Norian LA, Eliason SL, Koretzky GA. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J Immunol. 158:1997;4602-4611.
25. Gomez J, Martinez-A C, Fernandez B, Garcia A, Rebollo A. Critical role of ras in the proliferation and prevention of apoptosis mediated by IL-2. J Immunol. 157:1996;2272-2281.
26. Gomez J, Martinez-A C, Fernandez B, Garcia A, Rebollo A. Ras activation leads to cell proliferation or apoptotic death upon IL-2 stimulation or lymphokine deprivation, respectively. Eur J Immunol. 27:1997;1610-1618.
27. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, et al. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity. 2:1995;341-351.
28. Zhang Y, Yao B, Delikat S, Bayoumy S, Lin XH, Basu S, McGinley M, Chan-Hui PY, Lichenstein H, Kolesnick R. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell. 89:1997;63-72.
29. Downward J. KSR: a novel player in the RAS pathway. Cell. 83:1995;831-834.
30. Herr I, Wilhelm D, Böhler T, Angel P, Debatin KM. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16:1997;6200-6208.
31. Watts JD, Gu M, Polverino AJ, Patterson SD, Aebersold R. Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc Natl Acad Sci USA. 94:1997;7292-7296.
32. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
33. Cahill MA, Peter ME, Kischkel FC, Chinnaiyan AM, Dixit VM, Krammer PH, Hordheim A. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene. 13:1996;2087-2096.
34. Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J, Davis RJ, Blenis J. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol Cell Biol. 17:1997;24-35.
35. Lenczowski JM, Dominguez L, Eder AM, King LB, Zacharchuk CM, Ashwell JD. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol. 17:1997;170-181.
36. Rausch O, Marshall CJ. Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol Cell Biol. 17:1997;1170-1179.
37. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 124:1994;619-626.
38. Rak J, Mitsuhashi Y, Erdos V, Huang S, Filmus J, Kerbel RS. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression. J Cell Biol. 131:1995;1587-1598.
39. Lin HJ, Eviner V, Prendergast GC, White E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol. 15:1995;4536-4544.
40. Ward RL, Todd AV, Santiago F, O'Connor T, Hawkins NJ. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis. Cancer. 79:1997;1106-1113.
41. Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Barrington RE, Windle JJ. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors. Cancer Res. 57:1997;600-603.
42. Khwaja A, Rodriguez-Viciana P, Wennström S, Warne PH, Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. of outstanding interest EMBO J. 16:1997;2783-2793 The ability of oncogenic Ras to protect epithelial cells from detachment-induced apoptosis is shown to be mediated by the Ras activation of the PI3-kinase PKB/Akt pathway rather than the Raf MAP kinase pathway. It is also demonstrated that matrix adhesion normally stimulates PI3-kinase and PKB/Akt in these cells, thus providing a survival signal.
43. Marte BM, Rodriguez-Viciana P, Wennström S, Warne PH, Downward J. PI 3-kinase and PKB/Akt act as an effector pathway for R-Ras. Curr Biol. 7:1997;63-70.
44. Yao RJ, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2006.
45. L and Bcl-2.
46. of outstanding interest Del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. of outstanding interest Science. 278:1997;687-689 This paper, together with [47], shows that PKB/Akt is capable of phosphorylating Bad with the resulting loss of its death-promoting function. This provides a possible link between PKB/Akt and apoptosis regulation; however, it should be noted that these experiments used overexpressed Bad and that many cells do not normally express Bad.
47. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241 See annotation [46].
48. Kinoshita T, Yokota T, Arai K, Miyajima A. Regulation of bcl-2 expression by oncogenic ras protein in hematopoietic cells. Oncogene. 10:1995;2207-2212.
49. Kinoshita T, Shirouzu M, Kamiya A, Hashimoto K, Yokoyama S, Miyajima A. Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21 ras in IL-3-dependent hematopoietic cells. Oncogene. 15:1997;619-627.
50. Cortez D, Stoica G, Pierce JH, Pendergast AM. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene. 13:1996;2589-2594.
51. Mayo MW, Wang C-Y, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin AS Jr. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. of outstanding interest Science. 278:1997;1812-1815 The function of the NF-κB pathway is shown to be required for survival of Ras transformed fibroblasts under normal culture conditions. Ras transformed cells must require the continued expression of NF-κB regulated genes to suppress an apoptotic signal acting through an unidentified pathway.
52. McKenna WG, Bernhard EJ, Markiewicz DA, Rudoltz MS, Maity A, Muschel RJ. Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts: influence of H-ras on the G2 delay. Oncogene. 12:1996;237-245.
53. Lebowitz PF, Sakamuro D, Prendergast GC. Farnesyl transferase inhibitors induce apoptosis of ras-transformed cells denied substratum attachment. Cancer Res. 57:1997;708-713.
54. Arends MJ, McGregor AH, Toft NJ, Brown EJ, Wyllie AH. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer. 68:1993;1127-1133.
55. Gardner AM, Johnson GL. Fibroblast growth factor-2 suppression of tumor necrosis factor a-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem. 271:1996;14560-14566.
56. Cleveland JL, Troppmair J, Packham G, Askew DS, Lloyd P, Gonzalez-Garcia M, Nunez G, Ihle JN, Rapp UR. v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene. 9:1994;2217-2226.
57. Wang HG, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Hovey L, Troppmair J, Rapp UR, et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene. 9:1994;2751-2756.
58. Wang HG, Rapp UR, Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
59. Wojnowski L, Zimmer AM, Beck TW, Hahn H, Bernal R, Rapp UR, Zimmer A. Endothelial apoptosis in Braf-deficient mice. Nat Genet. 16:1997;293-297.
60. Olivier R, Otter I, Monney L, Wartmann M, Borner C. Bcl-2 does not require Raf kinase activity for its death-protective function. Biochem J. 324:1997;75-83.